Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
源自突变 PIK3CA 的公共新抗原的免疫原性和治疗靶向性
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-022-01786-3
Smita S Chandran, Jiaqi Ma, Martin G Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu, Lauren B Banks, Fei Yi, Enric Vercher, Inaki Etxeberria, Watchain D Bestman, Arnaud Da Cruz Paula, Ilinca S Aricescu, Alexander Drilon, Doron Bete
